Organization

Rambam Medical Center

7 abstracts

Abstract
Exploratory biomarker analysis of the phase 3 KEYNOTE-604 study of pembrolizumab plus etoposide for extensive-stage SCLC.
Org: Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea, Memorial Sloan Kettering Cancer Center, Vall d’Hebron University Hospital/VHIO, Lausanne University Hospital, William Osler Health System,
Abstract
Rectal spacer in radiotherapy for prostate cancer: Correlation of spacer symmetry to rectal dosimetry.
Org: Rambam Medical Center, Haifa, Israel, Israeli Medical Research Center, Technion Israel Institue of Technology, Rambam Health Care Campus,
Abstract
Dose escalation results from a first-in-human study of ABBV-400, a novel c-Met–targeting antibody-drug conjugate, in advanced solid tumors.
Org: START Midwest, Grand Rapids, MI, National Cancer Center Hospital East, Kashiwa, Japan, University of Colorado Cancer Center, Rambam Medical Center, Next Oncology Virginia and Virginia Cancer Specialists,
Abstract
Mirzotamab clezutoclax as monotherapy and in combination with taxane therapy in relapsed/refractory solid tumors: Dose expansion results.
Org: Legorreta Cancer Center, Brown University - Lifespan Cancer Institute, Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy, Clinical Research Institute at Rambam, Rambam Medical Center,
Abstract
Treatments and clinical outcomes in stage II colon cancer (CC) patients (pts) with 12-gene Oncotype DX Colon Recurrence Score assay-guided therapy: Real-world data.
Org: Rabin Medical Center Davidoff Cancer Centre, Lin Medical Center, Hadassah-Hebrew University Medical Center, Soroka University Medical Center, Tel Aviv Sourasky Medical Center,
Abstract
Metastases harbored in the maxillofacial region: Patient and cancer related characteristics and outcomes.
Org: Rambam Medical Center, Haifa, Israel, Israeli Medical Research Center, Emek Medical Center, Afula,
Abstract
AORTITIS PRESENTING AS FEVER OF UNKNOWN ORIGIN – FDG PET FOR DIAGNOSIS AND FOLLOW UP
Org: Department of Internal Medicine E, Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, The B. Shine Department of Rheumatology, Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary, Rambam Medical Center,